Pulsatilla chinensis functions as a novel antihyperlipidemic agent by upregulating LDLR in an ERK-dependent manner.

Song WF, Wang RJ, Yao RX, Jiang QY, Feng J, Luo K, Di ZH, Ma CM, Xie L

Open source

DOI
10.1186/s13020-024-01044-3
Published
2024 Dec 19
Container
Chinese medicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s13020-024-01044-3,
  title = {Pulsatilla chinensis functions as a novel antihyperlipidemic agent by upregulating LDLR in an ERK-dependent manner.},
  author = {Song WF and Wang RJ and Yao RX and Jiang QY and Feng J and Luo K and Di ZH and Ma CM and Xie L},
  year = {2024},
  journal = {Chinese medicine},
  doi = {10.1186/s13020-024-01044-3},
  url = {https://doi.org/10.1186/s13020-024-01044-3}
}

RIS

TY  - JOUR
TI  - Pulsatilla chinensis functions as a novel antihyperlipidemic agent by upregulating LDLR in an ERK-dependent manner.
AU  - Song WF
AU  - Wang RJ
AU  - Yao RX
AU  - Jiang QY
AU  - Feng J
AU  - Luo K
AU  - Di ZH
AU  - Ma CM
AU  - Xie L
PY  - 2024
JO  - Chinese medicine
DO  - 10.1186/s13020-024-01044-3
UR  - https://doi.org/10.1186/s13020-024-01044-3
ER  - 

APA

WF, S., RJ, W., RX, Y., QY, J., J, F., K, L., ZH, D., CM, M., & L, X. (2024). Pulsatilla chinensis functions as a novel antihyperlipidemic agent by upregulating LDLR in an ERK-dependent manner.. Chinese medicine. https://doi.org/10.1186/s13020-024-01044-3

Source records